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Abstract A Chinese hamster ovary (CHO) cell line, CHO-
ORL l 5 stably expressing human opioid receptor-like receptor 1 
(ORLi) has been used to determine ORLi-mediated signaling 
events using microphysiometry. Nociceptin/orphanin FQ (N/ 
OFQ), a specific endogenous agonist of ORLx, induced an 
increase in extracellular acidification rate (ECAR) in CHO-
ORLi cells. The ECAR response stimulated by N/OFQ was 
concentration-dependent and pertussis toxin-sensitive. Repeated 
exposures of the cells to N/OFQ caused desensitization of 
ORLi . The ECAR response was recovered at the half-life of 
approximately 12 min after the initial challenge. Pretreatment 
with inhibitor of cAMP-dependent kinase did not affect 
desensitization of ORLi . However, specific inhibitors for protein 
kinase C almost abolished N/OFQ-induced desensitization of 
extracellular acidification responsiveness, indicating the involve-
ment of protein kinase C in the process. 
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1. Introduction 
Opioid receptors belong to the G-protein-coupled receptor 
family that is characterized by the seven t ransmembrane span-
ning domains in structure. Activation of opioid receptor in-
hibits adenylyl cyclase activity [1]. There are three opioid re-
ceptor subtypes: u,, 8, and K. They mediate numerous 
physiological and pharmacological effects through interaction 
with opioids. Their essential role in opioid-induced analgesia 
has been demonstrated in the opioid receptor knock-out 
mouse by Matthes et al. recently [2]. 
Opioid receptor-like receptor 1 (ORLi) , a new member of 
the family of G-protein coupled receptors, has been cloned 
from brain recently [3-9]. It does not bind classical opioid 
ligands [6] and was considered an orphan receptor until its 
endogenous specific agonist nociceptin/orphanin F Q (N/OFQ) 
was identified [10,11]. In spite of the structure similarities that 
O R L i and N / O F Q share with opioid receptors and opioid 
peptides, N / O F Q has been shown to reverse analgesia induced 
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protein kinase; BSA, bovine serum albumin; LPA, lysophosphatidic 
acid 
by opioids [10,11]. The molecular and cellular basis of the 
anti-opioid effects mediated by ORLi remains to be under-
stood. 
Recent studies have demonstrated that interaction of N/ 
O F Q with O R L i results in activation of membrane-associated 
G protein, inhibition of adenylyl cyclase activity and increase 
of inwardly rectifying K + conductance in neuronal and non-
neuronal cells [10-15]. In our earlier work, we observed that 
O R L i undergoes acute and homologous desensitization 
[13,15]. In the present study, we have demonstrated that acti-
vation of O R L i increased extracellular acidification rate rap-
idly by using a microphysiometer, a real-time and non-inva-
sive system for monitoring the fast cellular response. Our 
results also indicate that desensitization of ORLi-st imulated 
extracellular acidification involves protein kinase C (PKC). 
2. Materials and methods 
2.1. Cell culture 
Chinese hamster ovary (CHO) cells (American Type Culture Col-
lection) were cultured in DMEM (Gibco-BRL) containing 10% heat-
inactivated fetal calf serum (Evergreen). CHO-ORLi cells stably ex-
pressing human ORLi were cultured in F12 medium (Gibco-BRL) 
containing 10% heat-inactivated fetal calf serum and 0.2 mg/ml Ge-
neticin (Gibco-BRL). All culture media were supplemented with 100 
units/ml penicillin, 100 ug/ml streptomycin and 2 mM glutamine. 
2.2. Construction of CHO-ORL\ stable cell line 
The cDNA for the human ORLi was isolated by PCR directly from 
human brain cDNA (Clontech Laboratories, CA, USA). Oligonucleo-
tide primers, based on the published sequence [3], were used to am-
plify a 1.1 kb fragment containing the entire coding sequence of 
ORL]. This fragment was cloned into pCDNA3 (Invitrogen) and 
nucleotide sequence analysis was performed using the Sequenase 2.0 
DNA sequencing kit (Amersham) according to the manufacturer's 
suggested protocols. CHO cells were transfected with pCDNA3 carry-
ing human ORL] insert by calcium phosphate precipitation [16]. A 
Geneticin-resistant clone expressing human ORLi (CHO-ORLi) was 
isolated and used in this study. 
2.3. Microphysiometry 
Extracellular acidification rates were measured with the silicon-
based light addressable potentiometer Cytosensor Microphysiometer 
(Molecular Devices Corp., CA, USA). CHO-ORLi cells were seeded 
at 1 X 10° cells/capsule cup (Molecular Devices Corp.). After the cells 
adhered to the capsule membrane and were cultured overnight, a 
spacer gasket and capsule insert (Molecular Devices Corp.) were 
placed into each capsule cup. The assembled capsule cups were loaded 
into Cytosensor chambers. Low buffering, carbonate-free DMEM 
(Gibco-BRL) was used as medium in the Cytosensor, and the extra-
cellular acidification rates were monitored, collecting a rate measure-
ment every 90 s. Cells were exposed to N/OFQ in running medium 
(0.1 ml/min) for 335 s, and the effects on the extracellular acidification 
rate were measured by the instrument. The basal acidification rate was 
normalized to 100%. 
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3. Results and discussion 
CHO-ORLi, a CHO cell line stably expressing human 
ORLi, was used in this study. Expression of ORLi was con-
firmed by Northern analysis with ORLi-specific cDNA probe, 
radioligand binding and agonist-dependent [35S]GTPyS bind-
ing assays (data not shown). Functional responses mediated 
by ORLi in CHO-ORLi cells were accessed in real-time scale 
by a microphysiometer which measures changes in the rate at 
which cells acidify their environment. Perfusion of 10 nM N/ 
OFQ increased the extracellular acidification rate of CHO-
ORLi cells to approximately 150% of the unstimulated rate 
within 5-10 min (Fig. 1A). The effect of N/OFQ on the ex-
tracellular acidification rate measured in the microphysiome-
ter was concentration-dependent. As shown in Fig. 2A, the 
extracellular acidification response to N/OFQ occurred at 0.1 
nM concentration of N/OFQ and reached maximum at 10 
nM. The EC50 (0.6 ±0.1 nM) for N/OFQ-stimulated extra-
cellular acidification was determined. This value is compara-
ble to those for N/OFQ-stimulated GTPyS binding (0.5 nM) 
measured in this study and for N/OFQ-stimulated attenuation 
of cellular cAMP production (0.7-1 nM) reported previously 
[11-13,15] using CHO cells transfected with ORLi. Pertussis 
toxin, a specific inhibitor of Gi/Go protein, completely 
blocked the cellular response to N/OFQ (Fig. IB), indicating 
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Fig. 1. Changes in ECAR in response to N/OFQ. A: CHO-ORLi 
cells were exposed to 10 nM N/OFQ for 6 min twice with a time in-
terval of 12 min. The figure is representative of three independent 
experiments. B: Cells in capsules were pretreated with or without 
100 ng/ml PTX for 24 h, and then exposed to 10 nM of N/OFQ or 
100 nM LPA for 6 min in the microphysiometer. The data are aver-
ages from at least three experiments. Student's /-test was used for 
statistical analysis of data. *P<0.05 as compared with the value 
without treatment. The basal acidification rate was normalized to 
100%. 
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Fig. 2. Desensitization of N/OFQ-stimulated ECAR response. A: 
The peak values of N/OFQ-induced EACR change with or without 
10 nM N/OFQ pretreatment were plotted in the figure separately 
with an EC50 of 1.6 ±0.1 nM and 0.6 ±0.1 nM respectively. B: 
CHO-ORLi cells were challenged twice with 10 nM N/OFQ at vari-
ous time intervals as indicated in the figure. The peak ECAR values 
in response to the second agonist treatment were plotted as % of 
peak ECAR of the initial treatment in the figure. The values on the 
plot represent the averages of at least three experiments. 
that the metabolic response stimulated by N/OFQ was medi-
ated through Gi/Go protein. 
Desensitization of opioid receptors, the reduced responsive-
ness of opioid receptor/Gi system after opioid stimulation, has 
been implicated in the molecular mechanisms underlying 
opioid tolerance. We have demonstrated recently, using 
cAMP assay, that ORLi undergoes homologous desensitiza-
tion in neuronal cells [15]. However, the time dependence and 
the mechanism of desensitization of ORLi need to be further 
investigated. A microphysiometer monitors extracellular acid-
ification rate in real-time scale. Cellular response to stimuli 
can be repeatedly determined from the same sample in a mi-
crophysiometer. We have investigated the time course of de-
sensitization of ORLi receptor using microphysiometry in this 
study. As shown in Fig. 1A, ECAR response to N/OFQ de-
creased significantly after pretreatment with the same agonist 
at the same dosage while the time needed to reach the max-
imum response remained the same. After prechallenge with 
ORLi agonist, the concentration-response curve for N/ 
OFQ-stimulated ECAR response shifted toward the right 
(EC50 increased from 0.6 ±0.1 nM to 1.6 ±0.1 nM) and the 
N/OFQ-stimulated ECAR response reduced approximately 
50% (Fig. 2A). These data suggest that ORLi undergoes acute 
desensitization after agonist pretreatment. 
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Fig. 3. Agonist-dependent desensitization of ORI^ and involvement 
of PKC. A: Cells were pretreated with or without 10 nM of N/ 
OFQ, and then challenged again with 10 nM of N/OFQ or 100 nM 
LPA. B: Cells were treated twice with 10 nM of N/OFQ in a 12 
min interval after preincubation with none, 480 nM H89, 6.6 |rM 
chelerythrine chloride, or 80 nM Go 6976 for 15 min in the micro-
physiometer. The peak ECAR values in response to the second ago-
nist treatment were plotted as % of peak ECAR of the initial treat-
ment in the figure. The values on the plot represent the averages 
from at least three experiments. Student's Mest was used for statisti-
cal analysis of data. *P<0.05, **P<0.01, as compared with the val-
ue without N/OFQ pretreatment. 
The desensitization of ORLi was reversible and the time 
course for ORLi recovering from desensitization was deter-
mined. As shown in Fig. 2B, the ECAR response induced by 
N/OFQ was recovered rapidly after initial exposure to the 
ORLi agonist. The half-life of the functional recovery of 
ORLi was approximately 12 min and about 90% of the 
ECAR response was recovered within 36 min after the initial 
exposure. Lysophosphatidic acid (LPA), agonist of another 
Gj-protein-coupled receptor which is endogenously expressed 
in CHO cells, caused a pertussis toxin-sensitive increase in 
extracellular acidification in CHO-ORLi cells (Fig. IB). How-
ever, pretreatment of N/OFQ did not affect LPA-stimulated 
extracellular acidification (Fig. 3A). This indicates that the 
desensitization of ORLi is agonist-specific. 
Agonist-dependent desensitization of receptor-effector cou-
pling could involve several mechanisms at the cellular level. 
However, receptor sequestration and down-regulation may 
not account for the acute desensitization while protein phos-
phorylation could be a major determinant for uncoupling the 
system, as in the well studied pVadrenergic receptor [17] and 
the 5-opioid receptor systems [18]. Receptor phosphorylation 
has been implicated as one mechanism of receptor desensiti-
zation [19]. It has been shown that the inhibitor of protein 
kinases attenuates the development of tolerance to opioids, 
and activation of PKC significantly reduces the development 
of morphine dependence [20]. Our previous research has 
shown that the desensitization of the 8-opioid receptor re-
quires activation of PKC [18]. Therefore, the involvement of 
protein kinases in the process of desensitization of ORLi was 
investigated using cell-permeable protein kinase inhibitors. As 
shown in Fig. 3B, when cells were exposed to N/OFQ a sec-
ond time in a 12 min interval, the extracellular acidification 
response reduced to 50% of the initial agonist treatment at the 
same dosage. Pretreatment with H89 [21], a potent specific 
inhibitor of cAMP-dependent kinase (PKA) (AT; =48 nM), 
had no effect on the desensitization of ORLi ■ However, after 
pretreatment with the selective inhibitors of PKC, either che-
lerythrine chloride (K, = 0.66 uM) [22] or Go 6976 {K{ = 8 nM) 
[23], the extracellular acidification in response to the second 
exposure of N/OFQ was partially or completely restored (Fig. 
3B). These results clearly indicate that N/OFQ desensitizes 
ORLi through a mechanism that requires PKC not PKA. 
The PKC substrate involved in the desensitization of ORLi 
signaling is to be identified. Our previous research has dem-
onstrated that the agonist-induced acute desensitization is 
temporally parallel to the opioid receptor phosphorylation 
[19,24]. The phosphorylation of ORLi has not been reported. 
However, based on the similarities of ORLi and opioid re-
ceptors in the receptor-mediated signal transduction proc-
esses, it is conceivable to consider the ORLi receptor as a 
likely substrate of PKC. Work is currently underway in our 
laboratory to look into the mechanism of ORLi desensitiza-
tion and the possible role of receptor phosphorylation. 
A cytosensor microphysiometer measures the proton excre-
tion of cells accurately in real time [25]. Proton excretion, or 
extracellular acidification, depends largely on the energy con-
sumption of a cell. When cell surface receptors are triggered 
by ligands, the cellular metabolism is activated by second 
messenger pathways resulting in increased energy metabolism 
and extracellular acidification which can be measured by a 
microphysiometer. Activation of a wide variety of cell surface 
receptor types including p-adrenergic receptor, nerve growth 
factor, etc., has been studied using microphysiometry [25]. 
Microphysiometry can give not only valuable and rapid 
data regarding receptor activation but also information on 
the intracellular events that are stimulated upon agonist occu-
pation of a receptor. However, the effect of activation of an 
opioid receptor or opioid receptor homologue on extracellular 
acidification has not been documented. This is the first report 
showing that activation of a member of the opioid receptor/ 
opioid receptor-like receptor family causes an increase of ex-
tracellular acidification rate. We have also determined, using 
this method, that ORLi undergoes acute desensitization and 
that PKC is required for the desensitization of the ORLi-
mediated ECAR responsiveness. 
Opioids are clinically effective analgesic drugs while N/OFQ 
mediates an anti-opioid effect. Studying the interactions be-
tween those receptors and their endogenous ligands has great 
pharmaceutical and clinical importance but no antagonist of 
ORLi has been reported yet. Our finding that activation of 
ORLi stimulated rapid ECAR response therefore provides a 
useful screening tool for evaluating ligands for potential ther-
apeutic purposes. 
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